TG Therapeutics | TGTX - Koszty Sprzedaży I Administracji





Koszty Sprzedaży I Administracji Zmiana Data
AbbVie USD 3.89B 325M 2025-12
Alaunos Therapeutics USD 585K 84K 2025-09
Amgen USD 1.94B 237M 2025-12
Ardelyx USD 75.92M 7.69M 2025-12
Arrowhead Research USD 46.02M 8.84M 2025-12
Bayer EUR 4.05B 647M 2025-12
Biogen USD 545.2M 38.6M 2025-09
Corcept Therapeutics USD 114.74M 7.77M 2025-12
Curis USD 4.79M 100K 2024-06
Gilead Sciences USD 1.78B 425M 2025-12
Infinity Pharmaceuticals USD 3.75M 2.19M 2023-06
J&J USD 6.75B 831M 2025-12
Karyopharm Therapeutics USD 27.19M 442K 2024-12
Novartis USD 3.44B 128M 2025-12
Novavax USD 25.53M 1.34M 2025-12
PTC Therapeutics USD 87.2M 3.15M 2025-12
Puma Biotechnology USD 16.82M 8.15M 2024-09
Regeneron Pharmaceuticals USD 775M 117.2M 2025-12
Roche Holding CHF 7.28B 3.99B 2025-12
TG Therapeutics USD 50.73M 12.64M 2025-12
Verastem USD 12.28M 2.06M 2024-09
Vertex Pharmaceuticals USD 487M 41.9M 2025-12